Company type | Private |
---|---|
Industry | Pharmaceutical |
Founded | 1974 |
Founder | Barry Sherman |
Headquarters | Toronto, Ontario, Canada |
Area served | Worldwide[1] |
Key people | Allan Oberman, President & CEO |
Products | Generic drugs |
Revenue | CA$~2 billion in 2018 (in worldwide sales)[2] |
Number of employees | ~8,000 (2023)[3] |
Website | www |
Apotex Inc. is a Canadian pharmaceutical corporation.[4] Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion.[5] By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries.[2][6][7] Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure.
Apotex is a member of the Canadian Generic Pharmaceutical Association (CGPA),[8] the Generic Pharmaceutical Association (GPhA),[9] an associate member of the Canadian Animal Health Institute (CAHI),[10] the Canadian Association for Pharmacy Distribution Management (CAPDM),[11] as well as the Greater Toronto Area's Partners in Project Green.[12]